Collaborative Effort Unveils Promising Breakthrough in Psoriasis Treatment: Advanced Fusion Protein Enzymes Target Chronic Inflammation with Reduced Side Effects Dr. Benjamin Keselowsky (PI), Dr. Gregory Hudalla (Co-I), and their collaborators have received a $3.8M grant from the NIH National Institute… Read More
Keselowsky & Hudalla receive $3.8M grant from NIH NIAID